AIMS: A study was designed to assess the effects of a standardized instructional videotape on reducing interobserver variability for several commonly used observer dependent outcome measures. METHODS: During a single day, six rheumatologists independently examined six patients with osteoarthritis (OA) in a predetermined order using a Latin square design, before and after viewing a standardized videotape demonstrating 13 examination techniques. Reliability coefficients were calculated based on variance components of the analysis of variance (ANOVA) table. RESULTS: Prestandardization reliability coefficients were >0.80 for all measures and remained above 0.80 following the intervention. CONCLUSIONS: It is usually assumed that serial measurement in clinical trials should be performed by the same assessor because of concern regarding interobserver variability. However, the high levels of prestandardization interobserver reliability observed in this study indicate that, for these variables, serial measurements in a clinical trial could be made by different assessors, assuming they were equally skilled. This observation has important implications for outcome measurement in OA clinical trials. Although high levels of prestandardization reliability precluded the demonstration of any significant improvement, we speculate that the videotape might be effective in training less-experienced assessors. Reductions in observer variability have the potential to diminish sample size requirements for OA antirheumatic drug studies. The use of a videotape to achieve this goal offers cost and convenience advantages over one-on-one training procedures, and this method should be further assessed in less-experienced assessors.
AIMS: A study was designed to assess the effects of a standardized instructional videotape on reducing interobserver variability for several commonly used observer dependent outcome measures. METHODS: During a single day, six rheumatologists independently examined six patients with osteoarthritis (OA) in a predetermined order using a Latin square design, before and after viewing a standardized videotape demonstrating 13 examination techniques. Reliability coefficients were calculated based on variance components of the analysis of variance (ANOVA) table. RESULTS: Prestandardization reliability coefficients were >0.80 for all measures and remained above 0.80 following the intervention. CONCLUSIONS: It is usually assumed that serial measurement in clinical trials should be performed by the same assessor because of concern regarding interobserver variability. However, the high levels of prestandardization interobserver reliability observed in this study indicate that, for these variables, serial measurements in a clinical trial could be made by different assessors, assuming they were equally skilled. This observation has important implications for outcome measurement in OA clinical trials. Although high levels of prestandardization reliability precluded the demonstration of any significant improvement, we speculate that the videotape might be effective in training less-experienced assessors. Reductions in observer variability have the potential to diminish sample size requirements for OA antirheumatic drug studies. The use of a videotape to achieve this goal offers cost and convenience advantages over one-on-one training procedures, and this method should be further assessed in less-experienced assessors.
Authors: N Bellamy; S Carette; P M Ford; W F Kean; N G le Riche; A Lussier; G A Wells; J Campbell Journal: J Rheumatol Date: 1992-03 Impact factor: 4.666
Authors: R Altman; K Brandt; M Hochberg; R Moskowitz; N Bellamy; D A Bloch; J Buckwalter; M Dougados; G Ehrlich; M Lequesne; S Lohmander; W A Murphy; T Rosario-Jansen; B Schwartz; S Trippel Journal: Osteoarthritis Cartilage Date: 1996-12 Impact factor: 6.576
Authors: A V Klinkhoff; N Bellamy; C Bombardier; S Carette; A Chalmers; J M Esdaile; C Goldsmith; P Tugwell; H A Smythe; W W Buchanan Journal: J Rheumatol Date: 1988-03 Impact factor: 4.666
Authors: N Bellamy; W W Buchanan; J M Esdaile; A G Fam; W F Kean; J M Thompson; G A Wells; J Campbell Journal: J Rheumatol Date: 1991-11 Impact factor: 4.666
Authors: N Bellamy; T P Anastassiades; W W Buchanan; P Davis; P Lee; G A McCain; G A Wells; J Campbell Journal: J Rheumatol Date: 1991-12 Impact factor: 4.666
Authors: J E Pope; M Baron; N Bellamy; J Campbell; S Carette; I Chalmers; P Dales; J Hanly; E A Kaminska; P Lee Journal: J Rheumatol Date: 1995-07 Impact factor: 4.666
Authors: N Bellamy; C Anjema; T Chhina; N Dudek; B Hurley; B Landesman; L Probyn; J Hill; J Campbell Journal: Inflammopharmacology Date: 1999 Impact factor: 4.473
Authors: N Bellamy; C Anjema; N Alikhan; T Chhina; D Dhanoa; D Edelist; Z Esufali; F Ismail; J Hill; J Campbell Journal: Inflammopharmacology Date: 1999 Impact factor: 4.473
Authors: N Bellamy; C Anjema; T S Frankovic; N Horowitz; G C Mills; S Shulman; C Smith; J Hill; J Campbell Journal: Inflammopharmacology Date: 1999 Impact factor: 4.473
Authors: N Bellamy; C Anjema; D Dhanoa; A Joglekar; G C Mills; G Nesrallah; C Smith; C Ucar; J Hill; J Campbell Journal: Inflammopharmacology Date: 1999 Impact factor: 4.473